U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 10-16, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 10-16, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 07/11/2022
Location: Virtual
Subject: FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Association for Accessible Medicines Board of Directors, global CEO's and staff

Event Date: 07/11/2022
Location: Virtual
Subject: FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Reagan-Udall Foundation Board of Directors and staff

Event Date: 07/12/2022
Location: Virtual
Subject: World Orphan Drug Congress USA; Speaker: Accelerating the Progress in Rare Diseases Diagnosis and Treatment
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Government, industry, academia, and media

Event Date: 07/12/2022
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; Speaker: FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, and other registered guests

Event Date: 07/12/2022
Location: Virtual
Subject: FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from the American Hospital Association

Event Date: 07/14/2022
Location: Virtual
Subject: Listening Session: Collaborations with FDA
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from the Association of Food and Drug Officials

Event Date: 07/15/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups interested in infant formula issues

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/14/2022
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/12/2022
Location: Virtual
Subject: FDA / Biotechnology Innovation Organization Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Biotechnology Innovation Organization

Event Date: 07/14/2022
Location: Virtual
Subject: Harvard Medical School Undiagnosed Diseases Network Grand Round Webinar; Panelist: Therapeutic Discovery for Rare Disease Patients
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and patient stakeholders

Event Date: 07/15/2022
Location: Virtual
Subject: Genetic Engineering and Biotechnology News LumaCyte Webinar; Speaker: Rapid Bioprocess Analytics Needed to Drive Improvements in Product Consistency and Quality
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/12/2022
Location: Virtual
Subject: Patient Engagement Advisory Committee (PEAC) Meeting; Opening Remarks: Augmented Reality and Virtual Reality Medical Devices
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patients, caregivers, and representatives of patient organizations

Event Date: 07/13/2022
Location: Virtual
Subject: Acquisition Principles
FDA Participant/Group: WILLIAM MAISEL; BLETA VUNIQI; KIMBERLY LEWANDOWSKI-WALKER;
Non FDA Participant/Group: Bob White, Brett Wall, Brian Barry, Chris Harrold, Geoff Martha, Gerardine Finn, Greg Smith, Jennifer Doyle, Laura Mauri, Malia Lowe, Noel Colon, Olaf Hedrich, Rebecca Seidel, Sean Salmon, Yarmela Pavlovic (Medtronic);

Event Date: 07/15/2022
Location: Virtual
Subject: Remanufacturing of Medical Devices
FDA Participant/Group: MATTHEW HAZELETT; KATELYN BITTLEMAN; WILLIAM MAISEL; SUZANNE SCHWARTZ; LINDA RICCI; KEISHA THOMAS;
Non FDA Participant/Group: Dr. Binseng Wang (Sodexo); Larry Hertzler (The InterMed Group); Scott Trevino, Tim McGeath (TriMedx); Shelia O’Donnell (Crothall); Jennifer Keahl (Agiliti); Andrew Coats (Hall Render);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 07/12/2022
Location: Chicago, IL
Subject: Institute of Food Technologists; Speaker: What FDA is Doing About Contaminants and Chemicals in Foods
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of Institute of Food Technologists

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 07/14/2022
Location: Washington, DC
Subject: Non-Tobacco Nicotine Enforcement Actions
FDA Participant/Group: MICHELE MITAL; KIMBERLEE TRZECIAK; PAUL AGUILAR;
Non FDA Participant/Group: Bipartisan staffers for both the Senate Health, Education, Labor and Pensions (HELP) Committee and Energy and Commerce Committee

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 07/11/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: REBECCA CLUSTER; MATTHEW LUCIA; LAURA STETS; TONG ZHOU; ANDREW FIDLER; HOLLY ZAHNER; CARLO JOSE MERCADO; HEATHER LOMBARDI; ADAM ORR; ANDREW KANAREK; KIMON KANELAKIS; HARLAN HOWARD; ADAM MOYER; EMILY CORNWELL; CHARLI LONG; SUSAN BRIGHT-PONTE; STELLA LEE; LAURA EPSTEIN; LYNNE BOXER; SUSAN HOMIRE;
Non FDA Participant/Group: Members of Biotechnology Innovation Organization (BIO)

Event Date: 07/14/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: DAVID EDWARDS; ANNE NORRIS; JENNIFER ERICKSON; ANTONIA MONIQUE SENNETT; SIOBHAN DELANCEY; CHARLOTTE CONWAY; JEANETTE MURPHY;
Non FDA Participant/Group: Members of Pet Food Institute (PFI)

Event Date: 07/15/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: LINDSAY ALVAREZ;
Non FDA Participant/Group: Members of Veterinary Medicines Directorate (VMD) and Medicines and Healthcare Products Regulatory Agency (MHRA)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top